Nouveau Life Pharmaceuticals, Inc.

NOUV · OTC
Analyze with AI
12/31/2024
6/30/2007
6/30/2006
6/30/2005
Operating Activities
Net Income-$357-$257-$401
Dep. & Amort.$134$53$114
Deferred Tax$0$0$0
Stock-Based Comp.$0$0$0
Change in WC$92$20$61
Other Non-Cash$109$98$163
Operating Cash Flow-$23-$85-$64
Investing Activities
PP&E Inv.$0$0$0
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$0$0$0
Investing Cash Flow$0$0$0
Financing Activities
Debt Repay.$0$0$0
Stock Issued$20$78$58
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$21$83$57
Financing Cash Flow$21$83$57
Forex Effect$2$4$0
Net Chg. in Cash$0$3-$7
Supplemental Information
Beg. Cash$4$1$8
End Cash$4$4$1
Free Cash Flow-$23-$85-$64
Nouveau Life Pharmaceuticals, Inc. (NOUV) Financial Statements & Key Stats | AlphaPilot